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occur in 2-60% of patients using corticosteroids. These side effects frequently occur within the first 2-week period that corticosteroids are initiated and may vary from depression to mania, psychosis to delirium and insomnia. Studies showed that some risk factors are associated with the neuropsychiatric side effects of corticosteroid treatment. The most important factor is the dosage of corticosteroid treatment (1) (2) (3) .
Although it is suggested that corticosteroid treatment should be stopped or the dosage of corticosteroids should be decreased while treating cases with corticosteroidinduced neuropsychiatric side effects; with the cases that are not eligible for this option, it is suggested that antipsychotics or mood stabilizers be added to treatment (1) (2) (3) (4) .
We aim to describe a case with corticosteroid-induced mania treated successfully with quetiapine.
A 33-year-old married woman was hospitalized for nephrotic syndrome in the nephrology inpatient clinic.
S h e w a s d i a g n o s e d w i t h f o c a l s e g m e n t a l glomerulosclerosis 10 days prior to admission, and she had been administered (1 mg/kg) 60 mg/d oral prednisolone treatment since then. Although she did not have a history of psychiatric disturbance, she complained of insomnia and irritability. These complaints appeared just 1 week after the initiation of corticosteroid treatment.
She could sleep for only 2 hours a day for 2 consecutive days. She was referred to the psychiatry department with the complaint of insomnia. She said that she was having trouble with her friends as they felt that she was talking a lot. Neither the patient nor her family had a history of psychiatric illness, alcoholism or drug abuse.
On mental status examination, her mood was dysphoric, and affect was labile. Her speech was loud and a bit pressured. Her attention was distractible. Thought speed was accelerated.
The Young Mania score was found to be 33. We . When we evaluate our case, we can detect two risk factors: using a high dosage of corticosteroids and being a woman. Furthermore, the symptoms occurred on day 7 of steroid treatment, which is reported to be the most likely period for the development of neuropsychiatric side effects.
Although it is suggested that corticosteroid-induced mania be treated with mood stabilizers, atypical antipsychotics are also useful (8, 9) (9) . To the best of our knowledge, there is only one corticosteroid-induced mania case treated successfully with quetiapine in the literature (13) . We selected quetiapine due to its sedative and mood stabilizing effects (14) , and the dosage of 400 mg/d was found to be effective for keeping the disorder under control; however, remission could only be achieved after the corticosteroid treatment was stopped. This case would have a significant place in the literature as it shows that quetiapine alone is effective in controlling neuropsychiatric side effects of corticosteroid treatment and could be a useful agent for treating corticosteroid-induced mania even if it is impossible to stop corticosteroid treatment.
It is crucial to evaluate carefully and follow up patients who are receiving corticosteroid treatment and particularly those who have risk factors. Furthermore, it is suggested that quetiapine could be an effective agent for the treatment of corticosteroid-induced mania, and further studies are warranted in this field.
